S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Vicuron Pharmaceuticals (MM) (MICU)
Vicuron Pharmaceuticals (MM) (MICU) News

MICU

Vicuron (MICU)

Vicuron Pharmaceuticals (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MICU

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
09/14/2005	3:00AM	PR Newswire (US)	Pfizer Completes Acquisition of Vicuron Pharmaceuticals	NASDAQ:MICU
09/11/2005	12:00PM	PR Newswire (US)	Vicuron Pharmaceuticals - Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Expected Closing Date for Acquisition	NASDAQ:MICU
08/18/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Files New Drug Application (NDA) for Anidulafungin for Treatment of Invasive Candidiasis/Candidemia	NASDAQ:MICU
08/15/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Stockholders Approve Merger With Pfizer	NASDAQ:MICU
08/04/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Announces Second Quarter 2005 Financial Results	NASDAQ:MICU	Vicuron Pharmaceuticals (MM)
06/16/2005	1:00AM	PR Newswire (US)	Pfizer to Acquire Vicuron Pharmaceuticals to Extend its Research Commitment in Anti-Infectives	NASDAQ:MICU	Vicuron Pharmaceuticals (MM)
06/02/2005	2:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Receives Issued Patent for Dalbavancin Dosing by U.S. Patent and Trademark Office	NASDAQ:MICU
05/31/2005	2:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Files Amendment to Anidulafungin New Drug Application (NDA) for Treatment of Esophageal Candidiasis	NASDAQ:MICU
05/26/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference and the Pacific Growth	NASDAQ:MICU
05/17/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the 2005 Needham Biotech Conference	NASDAQ:MICU
05/11/2005	2:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Announces Extension of FDA Review of Dalbavancin New Drug Application	NASDAQ:MICU
05/09/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the Bear Stearns 2005 Healthcare Conference and the Banc of America Securities Healthcare	NASDAQ:MICU
05/05/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Announces First Quarter 2005 Financial Results	NASDAQ:MICU
04/28/2005	7:30AM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at Morgan Stanley Healthcare Unplugged Conference	NASDAQ:MICU
03/30/2005	4:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Extends Pfizer Deal to Develop Oral Antibiotics for Community Market	NASDAQ:MICU
03/10/2005	3:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Announces Fourth Quarter 2004 Financial Results	NASDAQ:MICU
03/10/2005	6:30AM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the SG Cowen & Co. 25th Annual Health Care Conference	NASDAQ:MICU
03/04/2005	1:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Provides Update on Novartis Peptide Deformylase Inhibitor Program	NASDAQ:MICU
02/25/2005	6:30AM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the Wells Fargo Securities Healthcare Conference	NASDAQ:MICU
02/24/2005	1:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Granted Priority Review of Dalbavancin NDA by FDA in Complicated Skin and Soft Tissue Infections	NASDAQ:MICU
02/17/2005	6:30AM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the BIO CEO & Investor Conference 2005	NASDAQ:MICU
02/07/2005	1:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Announces Phase 3 Trial Results Demonstrate Superiority of Anidulafungin Versus Fluconazole in Invasive	NASDAQ:MICU
01/24/2005	1:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Promotes David S. Krause, M.D., to Executive Vice President and Chief Medical Officer	NASDAQ:MICU
01/05/2005	6:30AM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the 23rd Annual JP Morgan Healthcare Conference	NASDAQ:MICU
12/21/2004	3:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Submits New Drug Application for Dalbavancin to U.S. Food and Drug Administration	NASDAQ:MICU
11/29/2004	6:30AM	PR Newswire (US)	Vicuron Pharmaceuticals to Present at the Lazard Freres & Co. Healthcare Conference	NASDAQ:MICU
11/04/2004	3:30PM	PR Newswire (US)	Vicuron Pharmaceuticals Announces Third Quarter 2004 Financial Results	NASDAQ:MICU
11/01/2004	1:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Announces Data at ICAAC Supporting Next-Generation Lincosamide Program	NASDAQ:MICU
11/01/2004	1:00AM	PR Newswire (US)	Vicuron Pharmaceuticals Announces Data at ICAAC Demonstrating Potency of Anidulafungin and Dalbavancin	NASDAQ:MICU
10/25/2004	7:30AM	PR Newswire (US)	Vicuron Pharmaceuticals Announces 40 Presentations at ICAAC Highlighting Pipeline and Late-Stage Products	NASDAQ:MICU

Showing the most relevant articles for your search:NASDAQ:MICU

1 2 3 Next >>

Globestar Therapeutics (PK)

Therapeutic Solutions (PK)

Emergent Health (PK)

Ethema Health (PK)

Golden Triangle Ventures (PK)

Kraig Biocraft Laborator... (QB)

Virexit Technologies (PK)

Code Green Apparel (PK)

Fannie Mae (QB)

New Momentum (PK)

Northwest Biotherapeutics (QB)

SMC Entertainment (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions